Financial Data and Key Metrics Changes - For the full year 2025, combined revenue grew approximately 4% to $2.1 billion, marking the highest full-year revenue for the company [9] - Adjusted EBITDA for the full year was approximately $312 million, with an adjusted EBITDA margin of 14.8% [24] - Full-year combined adjusted gross profit was $794 million, with an adjusted gross margin of 37.6%, up 14 basis points [19] Business Line Data and Key Metrics Changes - In the Inspection and Mitigation (I&M) segment, revenue was approximately $1.1 billion for 2025, roughly flat year-over-year, with adjusted gross margin at 27.8% compared to 28.5% in the prior year [19][20] - Consulting Engineering (CE) revenue was $714 million, up roughly 8% against 2024, with an adjusted gross margin of 47.0%, up 150 basis points [20][21] - Geospatial (Geo) revenue was $298 million, up roughly 6% against 2024, with an adjusted gross margin of 51.5%, down from 53.6% in the prior year [21] Market Data and Key Metrics Changes - Year-end backlog within CE and Geo was $1.07 billion, up about 10% from approximately $970 million last year [15] - Data center revenue increased significantly year-over-year, reaching nearly $70 million in 2025, more than doubling versus the prior year [12] - The federal funding lapse affected timing of work in Geo but did not result in material cancellations [14] Company Strategy and Development Direction - The company aims to accelerate organic growth with a focus on cross-selling and deeper client engagement across segments [10] - Plans to strengthen organizational alignment and cultural cohesion while driving margin expansion through cost management and service mix improvement [10][16] - A $200 million share repurchase program has been authorized to enhance capital allocation flexibility [32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver on growth targets, citing structural tailwinds in infrastructure reinvestment and regulatory compliance [34] - The company expects revenue for 2026 in the range of $2.15 billion to $2.25 billion, with adjusted EBITDA between $330 million and $355 million [27] - Anticipated growth in CE and Geo is expected to outpace growth in I&M for the full year [27] Other Important Information - A planned leadership transition was announced, with Ben Heraud set to become CEO effective March 31, 2026, succeeding Tal Pizzey [2][7] - The integration program is on track to deliver $25 million in cost synergies, with half expected to be realized during 2026 [26] Q&A Session Summary Question: Can you talk a little bit more about the integration process in a little more detail? - Management expressed high confidence in the integration process, focusing on communications and culture, with specific milestones being tracked [39] Question: Can you discuss the biggest potential synergies and go-to-market strategies? - Management highlighted exciting developments in cross-selling opportunities, particularly in the data center space, and emphasized the importance of servicing clients throughout the asset lifecycle [40][41] Question: What are your expectations on the inspection side for the energy and oil end markets? - Management indicated good visibility on planned outages and run and maintain contracts, suggesting stability in the energy sector [48] Question: Could you elaborate on the timing and rationale for the CEO transition? - The transition was planned as part of succession planning, allowing for a unified culture and strategic continuity [56] Question: How could the current situation in the Middle East and rising oil prices impact your business? - The Middle East represents a small portion of the business, and current impacts from rising oil prices are minimal, with potential for increased work around pipelines [60] Question: Can you talk about the primary variables that could affect revenue guidance? - Management expressed high confidence in revenue guidance, citing strong tailwinds across all end markets [62]

Financial Data and Key Metrics Changes - For the full year 2025, the company generated revenue of $120.5 million, representing nearly 9% year-over-year growth [7] - In Q4 2025, revenue reached $34.4 million, up nearly 22% year-over-year, indicating accelerating momentum [7] - GAAP net income for 2025 was $10.8 million, a year-over-year increase of more than 37%, with earnings per share of $0.10 [7] - Adjusted EBITDA expanded to $27.5 million with a 23% margin, up more than 14% year-over-year [8] - Free cash flow reached approximately $20.5 million for 2025, compared to $13.2 million in 2024, representing growth of more than 500% from 2023 [8] Business Line Data and Key Metrics Changes - The company completed multiple acquisitions in 2025, including Medsphere Systems, which expanded its capabilities into the inpatient hospital market [10] - The integration of AI tools into the platform has already resulted in new customer wins under the CareCloud umbrella [11] - The company aims to penetrate newly acquired health system customers with its RCM and AI products as part of its 2026 growth strategy [12] Market Data and Key Metrics Changes - The healthcare technology market is at an inflection point, with AI adoption moving from pilot programs to production deployment [12] - The company recognizes a multi-billion-dollar addressable opportunity in the U.S. for its AI front desk assistant [12] Company Strategy and Development Direction - The company’s 2026 growth strategy focuses on leveraging its dual platform footprint in ambulatory and inpatient markets to drive organic growth and acquisition synergies [13] - Strategic acquisitions have been a cornerstone of growth, with a disciplined approach to acquiring companies at attractive valuations [14] - The company plans to remain active in M&A in 2026 and beyond, identifying complementary targets that can benefit from its AI capabilities [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue guidance of $128 million-$130 million for 2026, with adjusted EBITDA of $29 million-$31 million [15] - The company anticipates GAAP EPS of $0.20-$0.23 per share, representing an increase of more than 100% over 2025 [15] - Management highlighted the importance of disciplined execution and innovation to create long-term value for stakeholders [35] Other Important Information - The company resumed dividends on its preferred shares at the beginning of 2025 and plans to pay double dividends on Series B preferred stock starting in 2026 [9] - The conversion of approximately 80% of Series A preferred shares into common eliminated more than $7 million in annual dividend obligations [9] Q&A Session Summary Question: Can you expand on how you're planning on monetizing AI in 2026? - Management discussed the favorable M&A environment and the strategy to integrate AI capabilities into acquired platforms to enhance their attractiveness and market position [38][41] Question: What was behind the recent contract wins and future opportunities? - Management noted the expansion of the sales team and the focus on cross-selling additional services to existing clients acquired through recent transactions [45][46] Question: How does CareCloud's exposure to AI disruption compare to being an AI beneficiary? - Management emphasized that CareCloud operates in a niche healthcare IT space with deep industry moats, making it less vulnerable to generic AI disruptions [54][56] Question: What are the focuses for the use of excess cash flow? - Management indicated that the focus would be on acquisitions, enhancing capital structure, and investing in AI development [73] Question: Who are CareCloud's main competitors? - Management identified competitors in the EHR space such as eClinicalWorks and athenahealth, and noted that the AI competitive landscape varies depending on the product [75][76]

Financial Data and Key Metrics Changes - For Q4 fiscal 2026, consolidated revenues totaled $84.9 million, a decrease from $86.4 million in the prior year [29] - Net income for Q4 was $2.5 million, or $0.09 per diluted share, compared to a net loss of $5.4 million, or -$0.19 per diluted share in the previous year [30] - Gross margin improved to 47.8% of net revenues, up from 46.8% in the prior year [31] - SG&A expenses decreased by $10.6 million to $37.3 million, representing 43.9% of net revenues, down from 55.4% [32] - Operating income from continuing operations was $3.6 million, compared to an operating loss of $7.3 million in the prior year [33] Business Line Data and Key Metrics Changes - Direct segment revenues for Q4 were $74.5 million, a 2.6% decrease from $76.5 million in the prior year [30] - Indirect segment revenues increased by 4.9% to $10.4 million, driven by a large wholesale spring collaboration [31] - Comparable sales declined by 0.7%, showing sequential improvement throughout the fiscal year [30] Market Data and Key Metrics Changes - The company experienced a revenue decline of 1.7% overall in Q4, with indirect channel revenue growth of just under 5% [9] - The direct channel registered a revenue decline of 2.6%, but showed significant sequential improvement from previous quarters [8] Company Strategy and Development Direction - The company is focused on Project Sunshine, which aims to reclaim brand relevance and increase market share through five strategic pillars [4][7] - The leadership transition reflects confidence in the strategic direction and momentum of the company [3] - The company plans to stabilize sales between $255 million and $270 million for FY 2027, emphasizing a focus on rebuilding the wholesale business [5][36] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the transformation plans and the potential for long-term sustainable growth [27] - The company is optimistic about the early successes of Project Sunshine and the stabilization of the business [12][13] - Management acknowledged the need to navigate through inventory challenges from previous projects while building a strong foundation for future growth [40][41] Other Important Information - The company generated $17 million in operating cash flow in Q4, allowing for the payoff of its ABL facility [12] - Inventory decreased by nearly 17% year-over-year, with inventory turns improving to 1.6 from 1.5 [34][35] - The company will not hold its annual outlet sale in Q1 to focus on inventory for stores [36] Q&A Session Summary Question: When should product flows and mix be where the company wants them to be? - Management indicated that about 80% of the spring/summer product mix has been influenced, with a blank slate for fall/winter [39] Question: What is the focus on stores versus digital channels? - Management emphasized the importance of both digital and brick-and-mortar channels, with plans to optimize the existing store fleet and selectively open new brand stores [43][45] Question: Will more Outlet 2.0 stores open in FY 2027? - Management expressed an inclination to open a few more Outlet 2.0 stores in the fiscal year, refining the approach based on early results [47][50]

Financial Data and Key Metrics Changes - For Q4 2026, consolidated revenues totaled $84.9 million, a decrease from $86.4 million in the prior year [29] - Net income for Q4 was $2.5 million, or $0.09 per diluted share, compared to a net loss of $5.4 million, or -$0.19 per diluted share in the previous year [30] - Gross margin improved to 47.8% of net revenues, up from 46.8% in the prior year [31] - SG&A expenses decreased by $10.6 million to $37.3 million, representing 43.9% of net revenues, down from 55.4% [32] - Operating income from continuing operations was $3.6 million, compared to an operating loss of $7.3 million in the prior year [33] Business Line Data and Key Metrics Changes - Direct segment revenues for Q4 were $74.5 million, a 2.6% decrease from $76.5 million in the prior year [30] - Indirect segment revenues increased by 4.9% to $10.4 million, driven by a large wholesale spring collaboration [31] - Comparable sales declined by 0.7%, showing sequential improvement throughout the fiscal year [30] Market Data and Key Metrics Changes - The company experienced a positive year-over-year indirect channel revenue growth of just under 5% [9] - The direct channel registered a revenue decline of 2.6% compared to the prior year, but showed significant sequential improvement [8] Company Strategy and Development Direction - The company is focused on Project Sunshine, which aims to reclaim brand relevance and expand market share [4][5] - Five strategic pillars under Project Sunshine include sharpening brand focus, resetting go-to-market approach, rewiring digital ecosystem, implementing Outlet 2.0, and reimagining organizational structure [6][7] - The company plans to stabilize direct business and rebuild wholesale under new leadership, with sales guidance for FY 2027 set between $255 million and $270 million [5][35] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the transformation plans and the ability to deliver long-term sustainable results [5][27] - The company acknowledged the need to navigate through inventory challenges from previous management while focusing on product improvement [40] - Management views FY 2027 as a year for stabilization and building a foundation for growth in FY 2028 and beyond [41] Other Important Information - The company generated $17 million in operating cash flow in Q4, allowing for the payoff of its ABL facility [12] - Inventory decreased by nearly 17% year-over-year, with inventory turns improving to 1.6 from 1.5 [34] Q&A Session Summary Question: When should we feel that the product flows and product mix are where you want them to be? - Management indicated that about 80% of the spring/summer assortment has been influenced, and they expect to have full impact on fall/winter products [39] Question: Where should we be thinking about the depth and focus on stores versus digital? - Management emphasized the importance of both digital and brick-and-mortar channels, with plans to optimize existing stores and selectively open new brand stores [42][45] Question: Will more Outlet 2.0 stores open in FY 2027? - Management expressed inclination to open a few more Outlet 2.0 stores in FY 2027, refining the approach based on current learnings [50]

Financial Data and Key Metrics Changes - The company reported a net income from continuing operations of $21 million or $0.19 per share, a $49 million improvement compared to the prior year [5] - Adjusted EBITDA from continuing operations reached $50 million, an improvement of $48 million year-over-year [5] - Cash flow from continuing operations was $58 million, an increase of $44 million compared to 2024 [5] - For Q4, net sales grew by 9% year-over-year to just shy of $50 million, with net income from operations at $2.3 million and adjusted EBITDA of $8.6 million [13][26] Business Line Data and Key Metrics Changes - Global cannabis sales increased by 70% year-over-year, with significant contributions from the Netherlands business [4] - Canadian cannabis sales for Q4 were $52.7 million, a 10% increase compared to the same quarter last year, driven by international medicinal exports which grew by 384% [27] - Retail branded sales in Canada were flat compared to Q4 last year, but gross margins improved to 43%, above the target range of 30%-40% [14][28] Market Data and Key Metrics Changes - The company maintained a top five overall market share position in Canada and held the number one position in dried flower as of the end of the last month [14] - International export sales increased more than six-fold, benefiting from the company's leadership position as one of the largest EU GMP-certified cannabis operators [4] Company Strategy and Development Direction - The company is focused on improving margin performance, profitability, and cash generation to enable further growth investments [5] - The strategy includes a methodical approach to scaling operations, with a focus on high-margin products and international expansion [6][12] - The company is investing in capacity expansion projects in Canada and the Netherlands to meet increasing demand [20][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying fundamentals of the business, with strong demand domestically and internationally [19] - The company expects to return to sequential growth in international exports in Q1 and anticipates shipping to multiple new jurisdictions [19] - Management highlighted the importance of maintaining a balanced approach to capital allocation while pursuing growth opportunities [36] Other Important Information - The company ended the year with approximately $86 million in cash and a strong net cash position of $53 million [33] - The company has been active in its share repurchase program, purchasing nearly 813,000 shares at an aggregate cost of $3 million during Q4 [33] Q&A Session Summary Question: Share repurchases and capital allocation - Management indicated that share repurchases reflect confidence in cash generation and do not impact operational opportunities [39] Question: Growth in the German market - Management acknowledged a decline in import volumes but expects growth to resume, citing regulatory changes that favor their business model [41][42] Question: Capacity constraints and market share aspirations - Management clarified that Canadian operations remain a priority, balancing international demand with commitments in Canada [47] - The company regained its number one flower share position in January and expects continued growth in 2026 [48]

Financial Data and Key Metrics Changes - For the full year 2025, combined revenue grew approximately 4% to $2.1 billion, marking the highest full-year revenue for the company [10][20] - Adjusted EBITDA for the full year was approximately $312 million, with an adjusted EBITDA margin of 14.8% [10][25] - In the fourth quarter, total revenue was $508 million, reflecting a flat year-over-year performance, with adjusted gross profit increasing to $197 million, up 8% from the previous year [21][22] Business Line Data and Key Metrics Changes - In the Inspection and Mitigation (I&M) segment, revenue was approximately $1.1 billion for 2025, remaining roughly flat year-over-year, with adjusted gross margin at 27.8% [20] - Consulting Engineering (CE) revenue was $714 million, up roughly 8% against 2024, with an adjusted gross margin of 47.0% [20] - Geospatial (Geo) revenue was $298 million, up roughly 6% against 2024, with an adjusted gross margin of 51.5% [21] Market Data and Key Metrics Changes - Data center revenue increased significantly, reaching nearly $70 million in 2025, more than doubling from the prior year, with expectations to approach $100 million supported by contracted backlog [13][48] - Year-end backlog within CE and Geo was $1.07 billion, up about 10% from approximately $970 million last year [16] Company Strategy and Development Direction - The company aims to accelerate organic growth, focusing on cross-selling and deeper client engagement across segments [11][36] - A planned leadership transition was announced, with Ben Heraud set to become CEO on March 31, 2026, to ensure continuity and strategic execution [2][6] - The company is focused on margin expansion through prudent cost management and service mix improvement [11][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the structural tailwinds in markets, including infrastructure reinvestment and increasing regulatory complexity [36] - The company expects revenue for 2026 in the range of $2.15 billion to $2.25 billion, with adjusted EBITDA between $330 million and $355 million, indicating a growth outlook [28][29] Other Important Information - The company completed a $250 million private placement to strengthen its balance sheet and provide flexibility for growth opportunities [26] - An integration program is underway, targeting $25 million in cost synergies, with expectations to realize half of these savings in 2026 [27] Q&A Session Summary Question: Can you talk more about the integration process and specific milestones for 2026? - Management highlighted strong momentum in the integration process, focusing on communication and culture, with weekly meetings on milestones [41] Question: What are the biggest potential synergies and go-to-market strategies? - Management noted exciting developments in cross-selling opportunities, particularly in the data center space, and emphasized the ability to service clients throughout the asset lifecycle [42][43] Question: What are the expectations for the energy and oil end markets? - Management indicated good visibility on planned outages and run-and-maintain contracts, suggesting stability in the energy sector [55] Question: Can you elaborate on the EBITDA margins in the latest 2026 guidance? - Management acknowledged a lower EBITDA margin outlook due to a shift in compensation structure but emphasized growth and margin expansion from improved execution [62] Question: How does the current situation in the Middle East impact the business? - Management stated that the Middle East represents a small portion of the business, with minimal current impacts from rising oil prices [67] Question: What is the capital allocation strategy moving forward? - Management confirmed a robust tuck-in acquisition pipeline while maintaining flexibility for share buybacks based on market conditions [83][85]

Financial Data and Key Metrics Changes - Total fourth quarter revenue reached $11.3 million, representing a 37% year-over-year growth and a quarterly record, exceeding previous guidance [8][17] - Product revenue increased by 78% to $9.3 million in Q4, driven by strong system placements [10][17] - Recurring revenue, which includes consumables and service contracts, increased by 10% to $4.6 million [18] - Net loss for Q4 was $12.5 million, compared to a net loss of $9.7 million in the same quarter last year [22] Business Line Data and Key Metrics Changes - 16 Growth Direct systems were placed in Q4, a record number, bringing the total to 190 systems globally, with 155 fully validated [8][17] - Consumable revenue grew by 11% in Q4 compared to the previous year, indicating strong utilization across the installed base [18] - Service revenue was $2 million in Q4, down from $3 million in Q4 2024, primarily due to timing of validations [18] Market Data and Key Metrics Changes - The partnership with MilliporeSigma is entering its second year, with progress in establishing customer demo labs across Europe and Asia [11] - The expansion of the Growth Direct platform by Samsung Biologics highlights the demand for automation in pharmaceutical manufacturing [7][13] Company Strategy and Development Direction - The company aims to accelerate system placements, expand gross margins, innovate new products, and manage cash prudently [12][28] - A new cloud-native software platform is expected to be released in the second half of 2026, enhancing customer experience and providing AI-driven analytics [15][66] - The company anticipates revenue guidance for 2026 to be between $37 million and $41 million, with expectations for 30-38 system placements [15][24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving a gross margin of approximately 20% for 2026, driven by cost reductions and increased service revenue [16][27] - The company sees strong tailwinds in the market, including increased automation adoption and a focus on data integrity [14] - Management remains optimistic about the long-term growth potential in the pharmaceutical market, supported by partnerships and product innovations [13][28] Other Important Information - The company ended the year with $39 million in cash and investments, maintaining a strong liquidity position [23] - Operating expenses for Q4 were $11.9 million, slightly higher than the previous year, but total operating expenses for the full year decreased by 3% [20][22] Q&A Session Summary Question: What is being done to reduce the gap between placed and validated systems? - Management indicated that the gap is largely due to timing and expects to see improvements as they work with customers like Amgen to complete validations [31][32] Question: What percentage of placed systems are within CDMOs, and how is that space evolving? - Management noted a significant presence in CDMOs and emphasized the strong value proposition for both CDMOs and principal manufacturers [34][35] Question: What are the key drivers for achieving the 20% gross margin target for 2026? - Key drivers include locked-in product cost reductions, expected increases in service revenue, and higher manufacturing volumes [40][42] Question: How will the next-gen cloud-native software platform be integrated into existing systems? - The new platform will be a complete rewrite of the application software, providing easier integration and potential future revenue from cloud services [63][66] Question: What moves are being made to drive consumable cost reductions? - Management highlighted ongoing efforts with vendors to achieve significant cost reductions that will benefit margins in 2026 [69][71]

Financial Data and Key Metrics Changes - Full year net sales were $1.41 billion, in line with guidance despite reduced marketing spend and lower traffic [4] - Adjusted EBITDA was $78 million, exceeding guidance of $70 million [4] - Full year pro forma adjusted EBITDA margin was approximately 9%, a 200 basis point improvement versus the prior year [20] - Gross profit margin for Q4 was 55.6%, a 430 basis point decline year-over-year, primarily due to a non-recurring inventory obsolescence charge [18] - Full year gross margin was 59%, down 60 basis points year-over-year [20] - Total liquidity at year-end was $58 million, well above the amended $30 million covenant floor [20] Business Line Data and Key Metrics Changes - The launch of the ComfortMode mattress resulted in sales being 3.5 times what was expected, nearly twice the sales of the three c-series beds it replaces [7][8] - The ComfortMode bed has a gross margin improvement of 10 percentage points compared to the beds it replaces [31] Market Data and Key Metrics Changes - The company experienced significant sales declines in January due to store closures and macroeconomic impacts, with 236 stores closed for at least one day [6] - Sequential improvement in sales was observed in February and March, driven by the product launch [6] Company Strategy and Development Direction - The company is focused on a turnaround strategy that includes cost-cutting measures and a new product line launch [3][4] - A total of $185 million in annualized cost reductions have been executed, with an additional $50 million identified for 2026 [16][33] - The product line has been simplified from 12 mattresses to 7, organized into three clear collections to enhance customer experience [9] Management's Comments on Operating Environment and Future Outlook - Management acknowledged ongoing challenges in the industry, including severe weather and macroeconomic pressures [5] - The company expects Q1 net sales to decline in the high teens percentage but anticipates significant improvement in Q2 due to new product launches and increased marketing spend [23] - Adjusted EBITDA for the full year is expected to increase in the high teens to mid-20s percentage range year-over-year [23] Other Important Information - The company has engaged Guggenheim Securities to evaluate refinancing opportunities for its credit facility [14][24] - The marketing strategy has been modernized, with a focus on improving customer acquisition costs and brand consideration [12] Q&A Session Summary Question: What were the main pain points addressed by the new product launches? - The company aimed to expand its audience and focus on comfort, value, and durability in the new product line [27] Question: What are the major sources of the $50 million of additional savings? - The savings will come from logistics, delivery, labor model resets, and corporate overhead structure adjustments [33] Question: What is the phasing for getting the new beds across the portfolio? - The new beds will be available for purchase starting March 23rd, with most stores set by mid-April [46] Question: Will marketing spend increase in 2026? - Marketing spend will be held flat in 2026 compared to 2025, with a more even distribution throughout the year [59] Question: Will the EBITDA growth translate into positive free cash flow for the year? - Yes, the company expects positive free cash flow if the projected EBITDA growth is achieved [52]

Pharming Group (NasdaqGM:PHAR) Q4 2025 Earnings call March 12, 2026 08:30 AM ET Speaker8Good day, thank you for standing by. Welcome to the Pharming Group N.V. fourth quarter and full year 2025 financial results conference call and webcast. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, please press star one one on your telephone. You will then hear an automated message advising yo ...

Financial Data and Key Metrics Changes - Total revenues in 2025 were $176.4 million, flat compared to $175.7 million in 2024 [12] - Net income for 2025 was $1.7 million, a decrease of $8 million or 84.5% compared to $9.7 million in 2024 [32] - Adjusted EBITDA for 2025 was $35.6 million, a decrease of $7 million or 16.5% compared to $42.6 million for 2024 [31] - EBITDA for 2025 was $32.3 million, a decrease of $8.7 million or 21.2% compared to EBITDA of $41 million in 2024 [32] Business Line Data and Key Metrics Changes - RNG production in 2025 was approximately 5.6 million MMBtu, consistent with 2024 [15] - Revenues from the renewable natural gas segment in 2025 were $155.7 million, a decrease of $2.3 million or 1.4% compared to $158 million in 2024 [16] - Renewable electricity revenues in 2025 were $17.2 million, a decrease of $0.6 million or 2.9% compared to $17.8 million in 2024 [21] Market Data and Key Metrics Changes - The average realized RIN price in 2025 was $2.33, a decrease of approximately 29% compared to $3.28 in 2024 [12] - The natural gas index price increased approximately 51.1% during 2025, moving from $2.27 in 2024 to $3.43 in 2025 [13] Company Strategy and Development Direction - The company is evaluating additional development expansion opportunities to ensure the beneficial processing of all available feedstock volumes [4] - The commissioning of the Turkey, North Carolina facility is expected to process feedstock from approximately 400-450,000 hog spaces, with production and revenue generation activities anticipated to commence in April 2026 [9] - The company has completed a $200 million senior credit facility to support growth initiatives and the completion of the Turkey project [9][28] Management's Comments on Operating Environment and Future Outlook - Management expects RNG production volumes in 2026 to range between 5.8 and 6.1 million MMBtu, with corresponding RNG revenues between $175 million and $190 million [34] - The company anticipates renewable electricity production volumes in 2026 to range between 195,000 and 207,000 megawatt hours, with corresponding revenues between $35 million and $41 million [34] Other Important Information - Operating profit in 2025 was $0.9 million, a decrease of $15.2 million compared to $16.1 million in 2024 [25] - The company recorded impairment losses of $3.2 million for 2025, an increase of $1.6 million compared to $1.6 million for 2024 [22] - Capital expenditures for 2025 were approximately $116.5 million, with significant investments in Montauk Ag Renewables and other projects [29] Q&A Session Questions and Answers Question: What is built into your 2026 RNG production outlook? - Management indicated that growth is expected across all RNG sites due to landfill improvements and existing well field automation initiatives [37][38] Question: Can you triangulate your adjusted EBITDA potential growth? - Management noted that while they do not provide specific guidance on EBITDA, significant uplift is expected from the commissioning of the North Carolina turkey project and the reduction of non-repeated costs from 2025 [41][42][44] Question: Does the RNG revenue guidance reflect potential RIN price outcomes? - Management confirmed that the guidance covers various expectations, including production and potential RIN pricing, while noting that they have already committed and transferred their 2025 RINs [47][48]